These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15703428)

  • 21. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
    Lin OS; Keeffe EB; Sanders GD; Owens DK
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of screening for HIV.
    Taiwo BO
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15901873
    [No Abstract]   [Full Text] [Related]  

  • 24. Current world literature.
    Curr Opin HIV AIDS; 2010 May; 5(3):261-3. PubMed ID: 20539084
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.
    Sendi P; Günthard HF; Simcock M; Ledergerber B; Schüpbach J; Battegay M;
    PLoS One; 2007 Jan; 2(1):e173. PubMed ID: 17245449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating our way out of the HIV pandemic: could we, would we, should we?
    Garnett GP; Baggaley RF
    Lancet; 2009 Jan; 373(9657):9-11. PubMed ID: 19038439
    [No Abstract]   [Full Text] [Related]  

  • 27. Costs of eliminating HIV in South Africa have been underestimated.
    Wagner B; Blower S
    Lancet; 2010 Sep; 376(9745):953-4. PubMed ID: 20851250
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policy.
    Walensky RP
    Top HIV Med; 2009; 17(4):130-4. PubMed ID: 19890185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financial barrier to HIV treatment.
    Aust Nurs Midwifery J; 2014 Mar; 21(8):7. PubMed ID: 24724191
    [No Abstract]   [Full Text] [Related]  

  • 30. Is screening cost-effective for melamine-associated nephrolithiasis?
    Wang IJ; Huang YC; Chen PC; Wu TN
    J Trop Pediatr; 2011 Apr; 57(2):141-3. PubMed ID: 20601379
    [No Abstract]   [Full Text] [Related]  

  • 31. How many MSM in Europe could benefit from PrEP--a 9 billion Euro question?
    Kenyon CR; Osbak K
    Int J STD AIDS; 2015 Nov; 26(13):988-90. PubMed ID: 26490178
    [No Abstract]   [Full Text] [Related]  

  • 32. A normative analytic framework for development of practice guidelines for specific clinical populations.
    Owens DK; Nease RF
    Med Decis Making; 1997; 17(4):409-26. PubMed ID: 9343799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of antiretrovirals - long term or short term?
    Flessa S
    Appl Health Econ Health Policy; 2009; 7(4):225-7. PubMed ID: 19905036
    [No Abstract]   [Full Text] [Related]  

  • 34. How often should patients with diabetes be screened for retinopathy?
    Brown GC; Brown MM; Sharma S
    JAMA; 2000 Jul; 284(4):438; author reply 439. PubMed ID: 10904496
    [No Abstract]   [Full Text] [Related]  

  • 35. The power and pitfalls of simplifying assumptions.
    Roberts MS
    Med Decis Making; 1997; 17(4):496-7. PubMed ID: 9343809
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness analysis and HIV screening: the emergency medicine perspective.
    Hsu H; Walensky RP
    Ann Emerg Med; 2011 Jul; 58(1 Suppl 1):S145-50. PubMed ID: 21684394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does prevention pay?
    Meltzer D
    Med Care; 2015 Apr; 53(4):291-2. PubMed ID: 25769054
    [No Abstract]   [Full Text] [Related]  

  • 38. Some reflections on cost-effectiveness analysis.
    Johannesson M; Meltzer D
    Health Econ; 1998 Feb; 7(1):1-7. PubMed ID: 9541079
    [No Abstract]   [Full Text] [Related]  

  • 39. Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era.
    Farnham PG; Holtgrave DR; Gopalappa C; Hutchinson AB; Sansom SL
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):e15-8. PubMed ID: 24047975
    [No Abstract]   [Full Text] [Related]  

  • 40. Summaries for patients. Screening for HIV infection in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association.
    Ann Intern Med; 2009 Jan; 150(2):I-44. PubMed ID: 19047021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.